Ketogenic diet improves healthspan and memory in aging mice

Study on the effects of ketone bodies opens up new area of inquiry in aging research

September 5, 2017/Novato, CA A ketogenic diet significantly improved memory in aging mice and increased the animal’s chances of surviving to old age. Results of the study from Eric Verdin’s lab at the Buck Institute for Research on Aging in Novato, CA are published in the September 5th issue of Cell Metabolism.

Eating a ketogenic diet – which is high fat, low protein, and low carbohydrates - ramps up the production of the ketone body beta-hydroxybutyrate acid (BHB). While small studies in humans with cognitive impairment have suggested that BHB could improve memory, senior scientist and Buck President and CEO, Eric Verdin MD, says this is the first study in aging mammals which details the positive effects of BHB on memory and lifespan. “This opens up a new field in aging research,” said Verdin. “We think the health benefits of BHB may go beyond memory and could affect tissues and organ systems.” Verdin added that the results also support efforts in his lab to translate the findings to the clinic. “We’re looking for drug targets. The ultimate goal is to find a way for humans to benefit from BHBs without having to go on a restrictive diet.”

The study was designed by lead scientist John Newman, MD, PhD, who is both a researcher in the Verdin lab and a geriatrician at University of California San Francisco. He wanted to study the long-term effects of a ketogenic diet in mice, while addressing one of the major issues that crop up in research involving diet – variability. “When studying a diet intervention, you have to pay attention to every detail,” he said. Newman carefully designed three diets that were matched in every way except fat and carbohydrate content: a normal high-carbohydrate diet, a zero-carbohydrate ketogenic diet, and a high-fat, low-carbohydrate diet that was not ketogenic. Mice were fed the ketogenic diet intermittently to prevent them from becoming obese, starting at one year old – middle age for mice.

The ketogenic diet-fed mice had a lower risk of dying as they aged from one to two years old, although their maximum lifespan was unchanged. Another group of mice underwent memory testing at both middle age (one year old) and old age (two years old). Mice that had been eating a ketogenic diet performed at least as well on memory tests at old age as they did at middle age, while mice eating the normal diet showed an expected age-associated decline. Mice who ate the ketogenic diet also explored more, and their improved memory was confirmed with another test a few months later. Newman noted that the mice were off the ketogenic diet and did not have any BHB in their blood during the testing period. “We were careful to have all of the mice eating a normal diet during the actual memory testing which suggests the effects of the ketogenic diet were lasting. Something changed in the brains of these mice to make them more resilient to the effects of age,” he said. “Determining what this is, is the next step in the work.”

Newman said gene expression could explain the cognitive improvement. “Looking at gene expression, the ketogenic diet suppressed the longevity-related TOR pathway and insulin signaling and up-regulated the fasting-related transcription factor PPAR-alpha, a master regulator that helps the body more efficiently metabolize fat.”

Verdin said the study will open the door to new therapies for the cognitive problems of aging. “As we gain a deeper understanding of what BHB does in our body and our brain, we can intelligently design therapies to capture individual benefits while minimizing harms.” The Verdin lab is currently exploring beneficial effects of a similar ketogenic diet in a mouse model of Alzheimer’s disease.

The research has many caveats for humans eager to utilize diet to improve their odds of maintaining cognitive ability -- it involved a single strain and sex of mice living in an environment where it’s easy to control every aspect of the diet. Ketogenic diets are used clinically for life-threatening conditions like epilepsy, and most people should consult a health care professional before trying it on their own, said Verdin. “Exercise also creates ketone bodies – that may be one of the mechanisms why it shows such protective effects on brain function and on healthspan and lifespan,” he said.

Citation: Ketogenic diet reduces mid-life mortality and improves memory in aging mice DOI: 10.1016/j.cmet.2017.08.004

Other Buck Institute collaborators include Anthony J. Covarrubias, Minghao Zhao, and Che-Ping Ng. Other collaborators include Xinxing Yu, UCSF Division of Geriatrics, San Francisco, CA; Philip Gut, Gladstone Institute of Virology and Immunology, San Francisco, CA; and Yu Huang and Saptarsi Haldar from the Gladstone Institute of Cardiovascular Disease, San Francisco, CA.

The work was supported by grants from National Institutes of Health, K08AG048354 and R24DK085610; Gladstone Institutes intramural funds, Buck Institute intramural funds, and funds from the Larry L. Hillblom Foundation, Glenn Foundation for Medical Research, the American Federation for Aging Research and the Buck Institute Impact Circle.

A companion study by researchers at the University of California, Davis was published in the same issue of Cell Metabolism. That study showed that a ketogenic diet increased lifespan and strength in mice. For more information on that study, please contact Trina Davis. tdavis@ucdavis.edu, 530-752-5257.

About the Buck Institute for Research on Aging

The Buck Institute is the U.S.’s first independent research organization devoted to Geroscience – focused on the connection between normal aging and chronic disease. Based in Novato, California, the Buck is dedicated to extending “healthspan,” the healthy years of human life, and does so by utilizing a unique interdisciplinary approach involving laboratories studying the mechanisms of aging and others focused on specific diseases. Buck scientists strive to discover new ways of detecting, preventing and treating age-related diseases such as Alzheimer’s and Parkinson’s, cancer, cardiovascular disease, macular degeneration, osteoporosis, diabetes and stroke. In their collaborative research, they are supported by the most recent developments in genomics, proteomics, bioinformatics and stem cell technologies. For more information: www.thebuck.org.

Share:
Change text size:
smaller

default

bigger